Janus Henderson Just Took a 13.6% Stake in Vistagen. Should You Buy VTGN Stock Now?
The noted firm’s investment acts as a vote of confidence for this niche biotech company.
Barchart ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from VTGN
3 Biotech Penny Stocks to Avoid
The biotech industry thrived during the pandemic. However, that seems to be fading as the pandemic situation has relaxed. And given the inherent volatility of penny stocks, iBio (IBIO), VistaGen Therapeutics (VTGN), and Timber Pharmaceuticals (TMBR) might be best avoided amid the broader market turmoil. Read more….
StockNews.com ·
Looking Into VistaGen Therapeutics's Return On Capital Employed
Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
StockNews.com
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
